Follow the Corline Biomedical AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Corline Biomedical AB has logged 1 insider filings. Market capitalisation: €462.6m. The latest transaction was filed on 17 February 2026 (Purchase). Among the most active insiders: Henrik Nittmar. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Corline Biomedical AB es una empresa enfocada en el desarrollo de productos biofarmacéuticos. Se especializa en soluciones innovadoras para el tratamiento de enfermedades graves.